| Literature DB >> 29862510 |
Malgorzata Sierant1, Grazyna Leszczynska2, Klaudia Sadowska2, Patrycja Komar1, Ewa Radzikowska-Cieciura1, Elzbieta Sochacka2, Barbara Nawrot1.
Abstract
To date the only tRNAs containing nucleosides modified with a selenium (5-carboxymethylaminomethyl-2-selenouridine and 5-methylaminomethyl-2-selenouridine) have been found in bacteria. By using tRNA anticodon-stem-loop fragments containing S2U, Se2U, or geS2U, we found that in vitro tRNA 2-selenouridine synthase (SelU) converts S2U-RNA to Se2U-RNA in a two-step process involving S2U-RNA geranylation (with ppGe) and subsequent selenation of the resulting geS2U-RNA (with SePO33- ). No 'direct' S2U-RNA→Se2U-RNA replacement is observed in the presence of SelU/SePO33- only (without ppGe). These results suggest that the in vivo S2U→Se2U and S2U→geS2U transformations in tRNA, so far claimed to be the elementary reactions occurring independently in the same domain of the SelU enzyme, should be considered a combination of two consecutive events - geranylation (S2U→geS2U) and selenation (geS2U→Se2U).Entities:
Keywords: 2-selenouridine; 2-thiouridine; SelU; modified nucleoside; selenouridine synthase; tRNA
Mesh:
Substances:
Year: 2018 PMID: 29862510 DOI: 10.1002/1873-3468.13124
Source DB: PubMed Journal: FEBS Lett ISSN: 0014-5793 Impact factor: 4.124